Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
British Journal of Cancer|September 12, 2018
Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006Omid Hamid, Caroline Robert, Antoni Ribas, et al.Journal for Immunotherapy of Cancer|May 8, 2020
Efficacy of immune checkpoint inhibitors for in-transit melanomaEmilia Nan Tie, Julia Lai-Kwon, Michael Alexander Rtshiladze, et al.Molecular Cancer Therapeutics|October 16, 2004
Topoisomerase-II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxelVirginie Durbecq, Marianne Paesmans, Fatima Cardoso, et al.BJU International|March 31, 2022
High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centresElizabeth A Connolly, Andrew Weickhardt, Peter Grimison, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2016
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal CancerGuy A van Hazel, Volker Heinemann, Navesh K Sharma, et al.Cell|March 7, 2020
Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating AntibodiesHui Yi Chew, Priscila O De Lima, Jazmina L Gonzalez Cruz, et al.Journal for Immunotherapy of Cancer|April 23, 2020
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanomaJonathan S Cebon, Martin Gore, John F Thompson, et al.Nature Communications|May 31, 2023
Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapyMarjan M Naeini, Felicity Newell, Lauren G Aoude, et al.Pageof 4